Article Versions Notes

Bagratuni T, Patseas D, Mavrianou-Koutsoukou N, Liacos CI, Sklirou AD, Rousakis P, Gavriatopoulou M, Terpos E, Tsitsilonis OE, Trougakos IP, et al. Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity. Cancers. 2020; 12(10):2864. https://doi.org/10.3390/cancers12102864

Bagratuni, Tina, Dimitrios Patseas, Nefeli Mavrianou-Koutsoukou, Christine Ivy Liacos, Aimilia D. Sklirou, Pantelis Rousakis, Maria Gavriatopoulou, Evangelos Terpos, Ourania E. Tsitsilonis, Ioannis P. Trougakos, and et al. 2020. "Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity" Cancers 12, no. 10: 2864. https://doi.org/10.3390/cancers12102864

Bagratuni, T., Patseas, D., Mavrianou-Koutsoukou, N., Liacos, C. I., Sklirou, A. D., Rousakis, P., Gavriatopoulou, M., Terpos, E., Tsitsilonis, O. E., Trougakos, I. P., Kastritis, E., & Dimopoulos, M. A. (2020). Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity. Cancers, 12(10), 2864. https://doi.org/10.3390/cancers12102864